Citigroup Cuts UnitedHealth Group (UNH) Price Target to $247.00

UnitedHealth Group (NYSE:UNH) had its price objective decreased by Citigroup from $288.00 to $247.00 in a report issued on Wednesday, April 17th, BenzingaRatingsTable reports. Citigroup currently has a neutral rating on the healthcare conglomerate’s stock.

Other research analysts also recently issued research reports about the company. Barclays decreased their price objective on UnitedHealth Group from $290.00 to $270.00 and set an overweight rating on the stock in a report on Wednesday, April 17th. Morgan Stanley decreased their price objective on UnitedHealth Group from $315.00 to $285.00 and set an overweight rating on the stock in a report on Wednesday, April 17th. SunTrust Banks decreased their price objective on UnitedHealth Group to $300.00 and set a buy rating on the stock in a report on Wednesday, April 17th. They noted that the move was a valuation call. Credit Suisse Group reiterated a buy rating and issued a $310.00 price objective on shares of UnitedHealth Group in a report on Friday, February 8th. Finally, Zacks Investment Research cut UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, December 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of Buy and an average price target of $288.74.

NYSE UNH opened at $237.97 on Wednesday. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. The stock has a market cap of $227.73 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 1.24 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.04 earnings per share. On average, analysts predict that UnitedHealth Group will post 14.7 EPS for the current fiscal year.

In other news, CEO David S. Wichmann acquired 20,000 shares of the business’s stock in a transaction on Friday, May 3rd. The shares were acquired at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the transaction, the chief executive officer now owns 904,367 shares in the company, valued at approximately $209,623,226.93. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $239.02, for a total value of $1,195,100.00. Following the sale, the director now directly owns 77,993 shares in the company, valued at $18,641,886.86. The disclosure for this sale can be found here. Insiders sold 27,930 shares of company stock worth $6,746,683 over the last three months. 0.87% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of the business. Moseley Investment Management Inc. bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $225,000. Bremer Bank National Association bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $1,612,000. Citizens Financial Group Inc RI boosted its position in shares of UnitedHealth Group by 3.4% in the 1st quarter. Citizens Financial Group Inc RI now owns 63,826 shares of the healthcare conglomerate’s stock worth $15,782,000 after purchasing an additional 2,126 shares in the last quarter. Advisor Group Inc. boosted its position in shares of UnitedHealth Group by 11.7% in the 1st quarter. Advisor Group Inc. now owns 112,969 shares of the healthcare conglomerate’s stock worth $27,947,000 after purchasing an additional 11,838 shares in the last quarter. Finally, IMA Wealth Inc. boosted its position in shares of UnitedHealth Group by 40.2% in the 1st quarter. IMA Wealth Inc. now owns 7,614 shares of the healthcare conglomerate’s stock worth $1,883,000 after purchasing an additional 2,184 shares in the last quarter. 87.49% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What is systematic risk?

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.